Physician profile
John E Castaldo
NPI 1518975036
$2,140.61
in general payments reported to CMS, 2019-2025
23 companies · $22.02 in 2025
The $22.02 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $575 · 2021: $637 · 2022: $246 · 2025: $22.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $22.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $22.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $387.30 | 2019-2021 | |
| Amgen INC. | $278.86 | 2019-2021 | |
| Genentech USA, INC. | $255.89 | 2019-2022 | |
| Csl Behring | $144.61 | 2020-2022 | |
| Lilly USA, LLC | $133.83 | 2019-2022 | |
| Lundbeck LLC | $122.77 | 2019-2022 | |
| Abbvie INC. | $114.60 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $91.54 | 2019-2021 | |
| Grifols USA, LLC | $88.56 | 2019-2021 | |
| Genzyme Corporation | $78.92 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $73.31 | 2019-2021 | |
| Adamas Pharmaceuticals, INC. | $64.13 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $51.31 | 2021 | |
| Sunovion Pharmaceuticals INC. | $47.36 | 2020-2021 | |
| Mdd US Operations, LLC | $47.14 | 2019-2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $23.24 | 2019-2021 | |
| Sk Life Science, INC. | $22.09 | 2021 | |
| Biogen, INC. | $21.52 | 2021 | |
| Ge Healthcare | $21.23 | 2019 | |
| Livanova USA, INC. | $20.59 | 2019 | |
| Boston Scientific Corporation | $19.59 | 2020 | |
| Avion Pharmaceuticals | $18.79 | 2022 | |
| Arbor Pharmaceuticals, INC. | $13.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Castaldo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.